Syschem (India) Ltd

A sharp decline of nearly 20% intraday has dragged Syschem (India) Ltd to its lowest price in 52 weeks at Rs 34.18 on 4 Aug 2026, marking a significant setback amid a volatile trading session.

Syschem (India) Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 14 May 2026. However, the analysis and financial metrics discussed below reflect the stock's current position as of 26 July 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Syschem (India) Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 14 May 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 15 July 2026, providing investors with the most up-to-date view of the stock’s fundamentals, returns, and technical outlook.

Syschem (India) Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 14 May 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 04 July 2026, providing investors with the most up-to-date view of the stock’s fundamentals, returns, and overall outlook.

Syschem (India) Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen a notable shift in its valuation parameters, moving from an attractive to a very attractive rating. This change reflects a significant improvement in price metrics such as the price-to-earnings (P/E) and price-to-book value (P/BV) ratios, positioning the stock as a compelling consideration for investors amid a challenging market backdrop.

Syschem (India) Ltd’s stock price declined to a fresh 52-week low of Rs.40 on 30 June 2026, marking a significant downturn amid broader market volatility and sector-specific pressures. The stock has underperformed its sector and benchmark indices, reflecting a challenging period for the company despite some positive financial indicators.

Syschem (India) Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 14 May 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 23 June 2026, providing investors with the most up-to-date insight into the stock’s fundamentals, valuation, financial trends, and technical outlook.

Syschem (India) Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 14 May 2026. However, the analysis and financial metrics presented here reflect the company’s current position as of 11 June 2026, providing investors with an up-to-date view of the stock’s fundamentals, returns, and overall outlook.

Syschem (India) Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 14 May 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 26 May 2026, providing investors with the latest insights into its performance and outlook.

Syschem (India) Limited, a micro-cap pharmaceutical company engaged in manufacturing active pharmaceutical ingredients (APIs) and intermediates, reported a dramatic revenue surge in Q4 FY26, though profit volatility and an unusually high tax rate raised questions about earnings quality. The stock, trading at ₹50.12 with a market capitalisation of ₹245.65 crores, has delivered a modest 12.25% return over the past year, underperforming its pharmaceutical sector peers whilst navigating significant operational challenges.

Syschem (India) Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable shift in its valuation parameters, prompting a downgrade in its mojo grade from Buy to Hold. This change reflects evolving market perceptions amid rising price-to-earnings and price-to-book ratios, signalling a transition from fair to expensive territory for investors.

Syschem (India) Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable shift in its valuation parameters, moving from a fair to an attractive rating. This change reflects a recalibration of price-to-earnings and price-to-book value metrics relative to historical averages and peer benchmarks, signalling a potentially opportune moment for investors to reassess the stock’s price attractiveness amid mixed market returns.

Syschem (India) Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Buy to Hold as of 14 May 2026. This revision reflects a reassessment across four critical parameters: quality, valuation, financial trend, and technicals. Despite impressive recent earnings growth and promoter confidence, the stock’s valuation and management efficiency have prompted a more cautious stance.

Syschem (India) Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen a notable shift in its valuation parameters, moving from a fair to an expensive rating. This change reflects evolving market perceptions and has implications for investors assessing the stock’s price attractiveness amid its recent performance and sector dynamics.